Home » Cardiovascular » FRISC II Trial (2006): Invasive vs non-invasive treatment in unstable CAD

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
FRISC trial on NSTEMI
FRISC II Trial Visual Summary

1999, Invasive compared with non-invasive treatment in unstable coronary-artery disease, The Lancet

The FRISC II trial established the role of early intervention in patients with UA/NSTEMI. The study compared maximal medical therapy or non invasive approach with intervention and showed significant decrease in the incidence of MI.

The combine MI and/or mortality was found to be significantly lower after 5 years in patients who underwent invasive approach compared with non invasive approach 19.9% vs. 24.5% (RR 0.81; 95% CI 0.69–0.95; P=0.009). The early vs late intervention question was later answered by the TIMACS trial.

FRISC II Trial (2006): Invasive vs non-invasive treatment in unstable CAD